ImpactRX appoints Gregory Ellis CEO
This article was originally published in Scrip
Executive Summary
ImpactRX, a provider of analytical models that demonstrate the impact of promotion on physician prescribing behaviour, has appointed Gregory Ellis president and chief executive officer. Mr Ellis joins ImpactRX from Rosetta, where he was a senior partner from 2002 to July 2011, helping the firm grow from $5 million to $240 million in annual revenue.